e-learning
resources
London 2016
Monday, 05.09.2016
Long-term outcomes of lung transplantation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Total lung capacity size matching in fibrosis lung transplantation
Agathe Delbove (Saint Herblain, France), Agathe Delbove, Isabelle Danner-Boucher, Michèle Treilhaud, Thierry Le Poivre, Alain Haloun, Antoine Magnan, Jean-Christian Roussel, François-Xavier Blanc
Source:
International Congress 2016 – Long-term outcomes of lung transplantation
Session:
Long-term outcomes of lung transplantation
Session type:
Thematic Poster
Number:
2548
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Agathe Delbove (Saint Herblain, France), Agathe Delbove, Isabelle Danner-Boucher, Michèle Treilhaud, Thierry Le Poivre, Alain Haloun, Antoine Magnan, Jean-Christian Roussel, François-Xavier Blanc. Total lung capacity size matching in fibrosis lung transplantation. Eur Respir J 2016; 48: Suppl. 60, 2548
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Novel lung function tests in patients with interstitial lung disease (ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Mode of influence of pulmonary rehabilitation to lung function changes after the lung resection for primary lung cancer
Source: Annual Congress 2013 –Lung surgery: preoperative assessment and postoperative outcome
Year: 2013
Lung function tests and survival in idiopathic pulmonary fibrosis after lung transplantation
Source: Eur Respir J 2005; 26: Suppl. 49, 335s
Year: 2005
What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Isolated reduction in residual volume on body plethysmography is an early indicator of parenchymal lung disease
Source: International Congress 2016 – Pathophysiological mechanisms at different levels: lung, airways, muscles and symptom perception
Year: 2016
The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Possible indication for surgical resection of lung cancer associated with combined pulmonary fibrosis and emphysema (CPFE)
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Effect of posture on lung clearance index (LCI) and lung volumes in children with early stage cystic fibrosis lung disease
Source: International Congress 2015 – Lung function: effects on method, machine and disease on the measurement
Year: 2015
The relation of six-minute walk test and lung function in interstitial lung disease
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
A trial of the measurement of dynamic lung compliance by the new method using photoplethysmography in patients with COPD and pulmonary fibrosis
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016
Effect of pirfenidone on IPF progression
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Cystic fibrosis lung disease assessed by lung clearance index
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Lung function measurements versus structural lung disease in CF
Source: Breathe 2008; 5: 65
Year: 2008
Changes in lung mechanics and gas exchange in patients with pulmonary sarcoidosis (PS)
Source: International Congress 2014 – Innovative technology and techniques in respiratory function
Year: 2014
Clinical data, lung function and cardiopulmonary exercise testing in CPFE (combined pulmonary fibrosis with emphysema). Results of a cohort of 20 patients
Source: International Congress 2014 – ILDs 6
Year: 2014
Pattern of diffusion disturbance in patients with interstitial lung diseases (ILDs)
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016
Correlation of high resolution CT patterns to pulmonary function tests in patients with interstitial lung diseases
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept